Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Material Event

I recall reading someones message after the share holder meeting that Pohl said $250M.  I know for sure it was between $225M and $250M. 

That was about a year and a half ago so I am going on memory.

All the best,

Steve

Share
New Message
Please login to post a reply